Intradermal injection of low dose human regulatory T cells inhibits skin inflammation in a humanized mouse model

Recent regulatory T cell (Treg) based clinical trials support their therapeutic potential in transplantation and auto-inflammatory diseases. However, large numbers of Treg are needed to accomplish therapeutic efficacy. Local injection at the site of inflammation (targeted delivery) may lower the num...

Descripción completa

Detalles Bibliográficos
Autores principales: Landman, Sija, de Oliveira, Vivian L., van Erp, Piet E. J., Fasse, Esther, Bauland, Stijn C. G., Joosten, Irma, Koenen, Hans J. P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030170/
https://www.ncbi.nlm.nih.gov/pubmed/29968819
http://dx.doi.org/10.1038/s41598-018-28346-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030170/
https://www.ncbi.nlm.nih.gov/pubmed/29968819
http://dx.doi.org/10.1038/s41598-018-28346-5

Ejemplares similares